The Role of -glycosylation in Cancer

Overview

Journal Acta Pharm Sin B

Publisher Elsevier

Specialty Pharmacology

Date 2024 Mar 15

PMID 38486989

Authors

Yu Lin

David M Lubman

Affiliations

Soon will be listed here.

Abstract

Despite advances in understanding the development and progression of cancer in recent years, there remains a lack of comprehensive characterization of the cancer glycoproteome. Glycoproteins play an important role in medicine and are involved in various human disease conditions including cancer. Glycan-moieties participate in fundamental cancer processes like cell signaling, invasion, angiogenesis, and metastasis. Aberrant -glycosylation significantly impacts cancer processes and targeted therapies in clinic. Therefore, understanding -glycosylation in a tumor is essential for comprehending disease progression and discovering anti-cancer targets and biomarkers for therapy monitoring and diagnosis. This review presents the fundamental process of protein -glycosylation and summarizes glycosylation changes in tumor cells, including increased terminal sialylation, -glycan branching, and core-fucosylation. Also, the role of -glycosylation in tumor signaling pathways, migration, and metabolism are discussed. Glycoproteins and glycopeptides as potential biomarkers for early detection of cancer based on site specificity have been introduced. Collectively, understanding and exploring the cancer glycoproteome, along with its role in medicine, implication in cancer and other human diseases, highlights the significance of -glycosylation in tumor processes, necessitating further research for potential anti-cancer targets and biomarkers.

Citing Articles

Urinary extracellular vesicle N-glycomics identifies diagnostic glycosignatures for bladder cancer.

Li Y, Fu B, Wang M, Chen W, Fan J, Li Y Nat Commun. 2025; 16(1):2292.

PMID: 40055327 PMC: 11889218. DOI: 10.1038/s41467-025-57633-9.

N-glycosylation of ACTRIIB enhances protein stability leading to rapid cell proliferation and strong resistance to docetaxel in nasopharyngeal carcinoma.

Qin Q, Li J, Shao Y, Liu L, Luo Z Braz J Med Biol Res. 2025; 58:e14368.

PMID: 39907411 PMC: 11793155. DOI: 10.1590/1414-431X2024e14368.

Glycosylation gene expression profiles enable prognosis prediction for colorectal cancer.

Li R, He S, Qin T, Ma Y, Xu K, Liu S Sci Rep. 2025; 15(1):798.

PMID: 39755729 PMC: 11700200. DOI: 10.1038/s41598-024-84300-8.

Molecular Mechanisms Underlying the Loop-Closing Dynamics of β-1,4 Galactosyltransferase 1.

Tian J, Jia W, Dong H, Luo X, Gong L, Ren Y J Chem Inf Model. 2024; 65(1):390-401.

PMID: 39737871 PMC: 11734692. DOI: 10.1021/acs.jcim.4c02010.

Identification of serum N-glycans signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling.

Liu S, Huang J, Liu Y, Lin J, Zhang H, Cheng L Clin Proteomics. 2024; 21(1):64.

PMID: 39609732 PMC: 11604001. DOI: 10.1186/s12014-024-09516-2.

References

Kaszuba K, Grzybek M, Orlowski A, Danne R, Rog T, Simons K . N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc Natl Acad Sci U S A. 2015; 112(14):4334-9. PMC: 4394299. DOI: 10.1073/pnas.1503262112. View

Yin H, An M, So P, Wong M, Lubman D, Yao Z . The analysis of alpha-1-antitrypsin glycosylation with direct LC-MS/MS. Electrophoresis. 2018; 39(18):2351-2361. PMC: 6077116. DOI: 10.1002/elps.201700426. View

Campbell I, Humphries M . Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011; 3(3). PMC: 3039929. DOI: 10.1101/cshperspect.a004994. View

Venkatachalam M, Weinberg J . New wrinkles in old receptors: core fucosylation is yet another target to inhibit TGF-β signaling. Kidney Int. 2013; 84(1):11-4. DOI: 10.1038/ki.2013.95. View

Zhu J, Huang J, Zhang J, Chen Z, Lin Y, Grigorean G . Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis. J Proteome Res. 2020; 19(8):3452-3466. PMC: 7429342. DOI: 10.1021/acs.jproteome.0c00270. View

Chen J, Tang Y, Huang S, Juan H, Wu L, Sun Y . A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res. 2011; 71(2):473-83. DOI: 10.1158/0008-5472.CAN-10-1303. View

Mereiter S, Magalhaes A, Adamczyk B, Jin C, Almeida A, Drici L . Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer. Biochim Biophys Acta. 2016; 1860(8):1795-808. DOI: 10.1016/j.bbagen.2015.12.016. View

Kim Y, Park J, Lee H, Lee S, Kim S . TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor. Biochem J. 2012; 445(3):403-11. PMC: 3462611. DOI: 10.1042/BJ20111923. View

Li J, Guillebon A, Hsu J, Barthel S, Dimitroff C, Lee Y . Human fucosyltransferase 6 enables prostate cancer metastasis to bone. Br J Cancer. 2013; 109(12):3014-22. PMC: 3859952. DOI: 10.1038/bjc.2013.690. View

10.

Tu C, Wu M, Lin Y, Kannagi R, Yang R . FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation. Breast Cancer Res. 2017; 19(1):111. PMC: 5629780. DOI: 10.1186/s13058-017-0904-8. View

11.

Ogawa K, Kobayashi T, Furukawa J, Hanamatsu H, Nakamura A, Suzuki K . Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis. Sci Rep. 2020; 10(1):321. PMC: 6962197. DOI: 10.1038/s41598-019-56947-1. View

12.

Shintani Y, Takashima S, Asano Y, Kato H, Liao Y, Yamazaki S . Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 2006; 25(13):3045-55. PMC: 1500974. DOI: 10.1038/sj.emboj.7601188. View

13.

Seales E, Jurado G, Brunson B, Wakefield J, Frost A, Bellis S . Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005; 65(11):4645-52. DOI: 10.1158/0008-5472.CAN-04-3117. View

14.

Yin H, Tan Z, Wu J, Zhu J, Shedden K, Marrero J . Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma. J Proteome Res. 2015; 14(11):4876-84. PMC: 4636958. DOI: 10.1021/acs.jproteome.5b00718. View

15.

Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich R . Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. J Proteome Res. 2012; 11(9):4541-52. DOI: 10.1021/pr300330z. View

16.

McEver R . Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015; 107(3):331-9. PMC: 4592324. DOI: 10.1093/cvr/cvv154. View

17.

Bull C, Stoel M, den Brok M, Adema G . Sialic acids sweeten a tumor's life. Cancer Res. 2014; 74(12):3199-204. DOI: 10.1158/0008-5472.CAN-14-0728. View

18.

Partridge E, Le Roy C, Di Guglielmo G, Pawling J, Cheung P, Granovsky M . Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 2004; 306(5693):120-4. DOI: 10.1126/science.1102109. View

19.

Isaji T, Im S, Kameyama A, Wang Y, Fukuda T, Gu J . A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for -glycan sialylation in cancer cells. J Biol Chem. 2019; 294(12):4425-4436. PMC: 6433072. DOI: 10.1074/jbc.RA118.005208. View

20.

Stanley P . A method to the madness of N-glycan complexity?. Cell. 2007; 129(1):27-9. DOI: 10.1016/j.cell.2007.03.022. View